These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3884646)

  • 1. Hyperthyroid Graves' disease causes insulin antagonism.
    Shen DC; Davidson MB
    J Clin Endocrinol Metab; 1985 May; 60(5):1038-41. PubMed ID: 3884646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretion and sensitivity in hyperthyroidism.
    Jap TS; Ho LT; Won JG
    Horm Metab Res; 1989 May; 21(5):261-6. PubMed ID: 2673961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of glucose and lipid metabolism by continuous indirect calorimetry in Graves' disease: effect of an oral glucose load.
    Randin JP; Scazziga B; Jéquier E; Felber JP
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1165-71. PubMed ID: 3840492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and hepatic insulin antagonism in hyperthyroidism.
    Shen DC; Davidson MB; Kuo SW; Sheu WH
    J Clin Endocrinol Metab; 1988 Mar; 66(3):565-9. PubMed ID: 3280588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
    Ratzmann KP; Witt S; Schulz B
    Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood glucose and insulin responses to oral glucose in hyperthyroidism].
    Pandolfi C; Pellegrini L; Dedè A
    Minerva Endocrinol; 1996 Jun; 21(2):63-5. PubMed ID: 9026683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and action in the hyperthyroid rat.
    Varnum B; Davidson MB; Venkatesan N
    Horm Metab Res; 1985 Aug; 17(8):383-6. PubMed ID: 2865201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry.
    Randin JP; Tappy L; Scazziga B; Jequier E; Felber JP
    Diabetes; 1986 Feb; 35(2):178-81. PubMed ID: 3510924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 induces insulin resistance in the hyperthyroid state.
    Miyauchi S; Matsuura B; Ueda T; Eguchi T; Tamaru M; Yamamoto S; Miyake T; Furukawa S; Abe M; Hiasa Y; Onji M
    Endocr J; 2013; 60(4):449-55. PubMed ID: 23257837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucose production and splanchnic glucose exchange in hyperthyroidism.
    Wennlund A; Felig P; Hagenfeldt L; Wahren J
    J Clin Endocrinol Metab; 1986 Jan; 62(1):174-80. PubMed ID: 3510000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients.
    Ikeda T; Fujiyama K; Hoshino T; Takeuchi T; Mashiba H; Tominaga M
    Metabolism; 1990 Jun; 39(6):633-7. PubMed ID: 2191191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting the course of diabetes mellitus in hyperthyroid patients.
    Hamada N; Ito K; Mimura T; Momotani N; Nishikawa Y; Fujii S; Morii H; Wada M
    Horm Metab Res; 1986 Apr; 18(4):260-3. PubMed ID: 3519414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The mechanism of glucose intolerance in patients with Graves' disease].
    Kondo Y; Suzuki S; Gomi Y; Mayumi K; Sakamaki T; Inoue T; Iino S
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1257-68. PubMed ID: 1291337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired pancreatic alpha-cell response in hyperthyroidism.
    Kabadi UM; Eisenstein AB
    J Clin Endocrinol Metab; 1980 Sep; 51(3):478-82. PubMed ID: 6997327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects.
    Moghetti P; Castello R; Tosi F; Zenti MG; Magnani C; Bolner A; Perobelli L; Muggeo M
    J Clin Endocrinol Metab; 1994 Jan; 78(1):169-73. PubMed ID: 8288700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
    Mano T; Kawakubo A; Yamamoto M
    Nagoya J Med Sci; 1994 Mar; 57(1-4):61-8. PubMed ID: 7898563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of insulin secretion and insulin resistance by hyperglycemic clamp in Graves disease patients with impaired glucose tolerance].
    Liang Z; Luo GC; Hu QH; Li MZ; Chen N; Yan DW; Chai J; Chen ZL; Li HY; Ou HT
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):559-61. PubMed ID: 17959079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.